Potassium nitrate fails to improve aerobic capacity or QoL in participants with HFpEF, unravels JAMA study Jacinthlyn Sylvia27 Dec 2024 8:30 AM ISTA new study published in the Journal of American Medical Association showed that individuals with heart failure with preserved ejection fraction...
TyG index significantly linked to heart failure with preserved ejection fraction, suggests study Jacinthlyn Sylvia20 Dec 2024 7:00 AM ISTA recent study published in the Frontiers in Endocrinology journal showed that heart failure with preserved ejection fraction (HFpEF) in patients with...
Finerenone Proven Effective in Reducing Heart Failure Events Across Genders in FINEARTS-HF Trial Medha Baranwal19 Dec 2024 9:00 AM ISTUK: In a secondary analysis of the FINEARTS-HF randomized clinical trial, researchers found that finerenone, a novel non-steroidal mineralocorticoid...
Anemia in heart failure with preserved ejection fraction associated with RV dysfunction, reveals research Jacinthlyn Sylvia13 Dec 2024 8:15 AM ISTA new study published in the Frontiers in Cardiovascular Medicine journal showed that right ventricular (RV) dysfunction is linked to anemia in heart...
Study Reveals Link Between TyG Index and Heart Failure with Preserved Ejection Fraction in Hypertensive Patients Medha Baranwal26 Oct 2024 9:00 AM ISTChina: A recent study published in PeerJ revealed a strong connection between insulin resistance (IR), as measured by the triglyceride-glucose (TyG)...
Greater Splanchnic Nerve Ablation Shows Feasibility but No Clinical Benefit in HFpEF Patients: REBALANCE-HF Trial Dr. Prem Aggarwal11 Oct 2024 9:00 AM ISTUSA: A recent study has emerged from the REBALANCE-HF randomized clinical trial, exploring the efficacy of endovascular ablation of the greater...
Mavacamten may Improve Cardiac Biomarkers in HFpEF Patients, Early trial Results Show Promise Dr. Prem Aggarwal8 Oct 2024 9:00 AM ISTUSA: A recent study from the EMBARK-HFpEF trial has revealed promising results regarding using mavacamten, a cardiac myosin inhibitor, in patients...
Ketone Ester Treatment Improves Heart Function in Type 2 Diabetes and HFpEF, New Study Finds Medha Baranwal26 Sept 2024 9:00 AM ISTDenmark: A recent randomized crossover trial has revealed promising results for a two-week oral ketone ester (KE) treatment in patients with Type 2...
Verinurad and Allopurinol Combination Lowers SUA Levels but Fails to Improve HFpEF Outcomes, AMETHYST Trial Finds Medha Baranwal4 Sept 2024 9:00 AM ISTUSA: In a recent clinical trial, the combination of verinurad and allopurinol demonstrated a notable reduction in serum uric acid (SUA) levels in...
Semaglutide Promotes Weight Loss and Improves HF Outcomes in Patients with Obesity-Related HFpEF: JACC Medha Baranwal8 Aug 2024 10:00 AM ISTUSA: Insights from the STEP-HFpEF program showed the efficacy of semaglutide in reducing N-terminal pro-B-type natriuretic peptide (NT-proBNP) in...
PASSION Trial's Premature End Highlights Tadalafil's Ineffectiveness and Possible Risks for HFpEF Patients Medha Baranwal5 Aug 2024 9:00 AM ISTGermany: The PASSION trial, which was halted early due to issues with the study medication supply, does not endorse tadalafil use for patients with...
New HFpEF-ABA Score Simplifies Screening for Undiagnosed HFpEF with Basic Patient Data: Study Medha Baranwal5 Aug 2024 9:00 AM ISTUSA: A recent advancement in cardiology promises to enhance the diagnosis and management of heart failure with preserved ejection fraction (HFpEF)...
